GARO H ARMEN

CIK 935679 · See Remarks · last filed 2026-06-02

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$24.91M

Companies

5

Total Filings

270

Lifetime Open-Market Net

$7.86M

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
AGEN See Remarks 387,265 $3.30 $1.28M $7.81M 256 2026-06-02
Protagenic Therapeutics, Inc.\new (PTIXW) Delisted Executive Chairman $0.01 $0 1 2024-03-29
INKT Director 1,966,400 $12.02 $23.64M $0 4 2023-05-26
AGENUS INC (AGEND) Delisted Chairman & CEO 1,746,471 $49.8K 1 2011-10-03
COLOR KINETICS INC (CLRK) Delisted Director 0 $0 4 2007-08-27

Recent Filings · Page 4 of 27

270 filings
Form 4 transactions across all companies, newest first.
Filed Symbol Action Net Shares Net $ Link
2025-05-05 AGEN Grant (A) +5,260 $16.4K EDGAR
2025-04-22 AGEN Grant (A) +7,886 $16.4K EDGAR
2025-04-08 AGEN Grant (A) +10,288 $16.0K EDGAR
2025-03-24 AGEN Grant (A) +9,243 $14.9K EDGAR
2025-03-11 AGEN Grant (A) +6,332 $14.9K EDGAR
2025-02-25 AGEN Grant (A) +4,483 $14.9K EDGAR
2025-02-11 AGEN Grant (A) +4,251 $14.9K EDGAR
2025-01-28 AGEN Grant (A) +4,169 $14.9K EDGAR
2025-01-13 AGEN Grant (A) +4,777 $14.9K EDGAR
2024-12-30 AGEN Grant (A) +5,931 $16.3K EDGAR
Showing 3140 of 270
Page 4 of 27
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.